384 related articles for article (PubMed ID: 32620839)
21. Understanding the mechanisms of efficacy of fecal microbiota transplant in treating recurrent
Martinez-Gili L; McDonald JAK; Liu Z; Kao D; Allegretti JR; Monaghan TM; Barker GF; Miguéns Blanco J; Williams HRT; Holmes E; Thursz MR; Marchesi JR; Mullish BH
Gut Microbes; 2020 Nov; 12(1):1810531. PubMed ID: 32893721
[TBL] [Abstract][Full Text] [Related]
22. Overcoming donor variability and risks associated with fecal microbiota transplants through bacteriophage-mediated treatments.
Rasmussen TS; Mao X; Forster S; Larsen SB; Von Münchow A; Tranæs KD; Brunse A; Larsen F; Mejia JLC; Adamberg S; Hansen AK; Adamberg K; Hansen CHF; Nielsen DS
Microbiome; 2024 Jul; 12(1):119. PubMed ID: 38951925
[TBL] [Abstract][Full Text] [Related]
23. Fecal microbiota transplantation for the treatment of Clostridium difficile infection.
Rao K; Safdar N
J Hosp Med; 2016 Jan; 11(1):56-61. PubMed ID: 26344412
[TBL] [Abstract][Full Text] [Related]
24. Is frozen fecal microbiota transplantation as effective as fresh fecal microbiota transplantation in patients with recurrent or refractory Clostridium difficile infection: A meta-analysis?
Tang G; Yin W; Liu W
Diagn Microbiol Infect Dis; 2017 Aug; 88(4):322-329. PubMed ID: 28602517
[TBL] [Abstract][Full Text] [Related]
25. Colonization potential to reconstitute a microbe community in patients detected early after fecal microbe transplant for recurrent C. difficile.
Kumar R; Maynard CL; Eipers P; Goldsmith KT; Ptacek T; Grubbs JA; Dixon P; Howard D; Crossman DK; Crowley MR; Benjamin WH; Lefkowitz EJ; Weaver CT; Rodriguez JM; Morrow CD
BMC Microbiol; 2016 Jan; 16():5. PubMed ID: 26758906
[TBL] [Abstract][Full Text] [Related]
26. Strain Tracking Reveals the Determinants of Bacterial Engraftment in the Human Gut Following Fecal Microbiota Transplantation.
Smillie CS; Sauk J; Gevers D; Friedman J; Sung J; Youngster I; Hohmann EL; Staley C; Khoruts A; Sadowsky MJ; Allegretti JR; Smith MB; Xavier RJ; Alm EJ
Cell Host Microbe; 2018 Feb; 23(2):229-240.e5. PubMed ID: 29447696
[TBL] [Abstract][Full Text] [Related]
27. Depletion of butyrate-producing microbes of the Firmicutes predicts nonresponse to FMT therapy in patients with recurrent
Tian H; Cui J; Ye C; Zhao J; Yang B; Xu Y; Ji S; Wang L; Lv X; Ma C; Zhou S; Li N; Wang X; Qin H; Chen Q
Gut Microbes; 2023; 15(1):2236362. PubMed ID: 37469017
[TBL] [Abstract][Full Text] [Related]
28. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
[TBL] [Abstract][Full Text] [Related]
29. Current applications of fecal microbiota transplantation in intestinal disorders.
Hsu WH; Wang JY; Kuo CH
Kaohsiung J Med Sci; 2019 Jun; 35(6):327-331. PubMed ID: 31017741
[TBL] [Abstract][Full Text] [Related]
30. Gut microbiota differs between treatment outcomes early after fecal microbiota transplantation against recurrent
Wei S; Bahl MI; Baunwall SMD; Dahlerup JF; Hvas CL; Licht TR
Gut Microbes; 2022; 14(1):2084306. PubMed ID: 36519447
[TBL] [Abstract][Full Text] [Related]
31. An Infectious Diseases Perspective on Fecal Microbiota Transplantation for Clostridioides difficile Infection in Children.
Cotter JM; Nicholson MR; Kociolek LK
J Pediatric Infect Dis Soc; 2019 Dec; 8(6):580-584. PubMed ID: 31550348
[TBL] [Abstract][Full Text] [Related]
32. The interplay of gut microbiota between donors and recipients determines the efficacy of fecal microbiota transplantation.
He R; Li P; Wang J; Cui B; Zhang F; Zhao F
Gut Microbes; 2022; 14(1):2100197. PubMed ID: 35854629
[TBL] [Abstract][Full Text] [Related]
33. Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial.
Kelly CR; Khoruts A; Staley C; Sadowsky MJ; Abd M; Alani M; Bakow B; Curran P; McKenney J; Tisch A; Reinert SE; Machan JT; Brandt LJ
Ann Intern Med; 2016 Nov; 165(9):609-616. PubMed ID: 27547925
[TBL] [Abstract][Full Text] [Related]
34. Fecal microbiota transplantation for irritable bowel syndrome: Current evidence and perspectives.
Dai C; Huang YH; Jiang M
World J Gastroenterol; 2024 Apr; 30(16):2179-2183. PubMed ID: 38690018
[TBL] [Abstract][Full Text] [Related]
35. Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure.
Lee CH; Chai J; Hammond K; Jeon SR; Patel Y; Goldeh C; Kim P
Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1731-1735. PubMed ID: 31165961
[TBL] [Abstract][Full Text] [Related]
36. New Procedure to Maintain Fecal Microbiota in a Dry Matrix Ready to Encapsulate.
Aira A; Rubio E; Ruiz A; Vergara A; Casals-Pascual C; Rico V; Suñé-Negre JM; Soriano A
Front Cell Infect Microbiol; 2022; 12():899257. PubMed ID: 35755849
[TBL] [Abstract][Full Text] [Related]
37. Fecal microbiota transplantation can improve cognition in patients with cognitive decline and
Park SH; Lee JH; Kim JS; Kim TJ; Shin J; Im JH; Cha B; Lee S; Kwon KS; Shin YW; Ko SB; Choi SH
Aging (Albany NY); 2022 Aug; 14(16):6449-6466. PubMed ID: 35980280
[TBL] [Abstract][Full Text] [Related]
38. Laboratory Testing of Donors and Stool Samples for Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.
Woodworth MH; Neish EM; Miller NS; Dhere T; Burd EM; Carpentieri C; Sitchenko KL; Kraft CS
J Clin Microbiol; 2017 Apr; 55(4):1002-1010. PubMed ID: 28077694
[TBL] [Abstract][Full Text] [Related]
39. Fecal microbiota transplantation: a review on current formulations in
Rakotonirina A; Galperine T; Allémann E
Expert Opin Biol Ther; 2022 Jul; 22(7):929-944. PubMed ID: 35763604
[TBL] [Abstract][Full Text] [Related]
40. Fecal microbiota transplantation for recurrent Clostridioides difficile infection.
Haber SL; Raney CRK; Larson TL; Lau JP
Am J Health Syst Pharm; 2019 Jun; 76(13):935-942. PubMed ID: 31361890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]